Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat.
about
Does low-energy sweetener consumption affect energy intake and body weight? A systematic review, including meta-analyses, of the evidence from human and animal studies.Physiological mechanisms by which non-nutritive sweeteners may impact body weight and metabolismThe Microbiome and Sustainable Healthcare.Functional and morphological changes in endocrine pancreas following cola drink consumption in ratsMethylsulfonylmethane: Applications and Safety of a Novel Dietary SupplementEnteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.Approaches to studying and manipulating the enteric microbiome to improve autism symptomsGastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.Dysbiotic drift: mental health, environmental grey space, and microbiota.An In Vivo Magnetic Resonance Spectroscopy Study of the Effects of Caloric and Non-Caloric Sweeteners on Liver Lipid Metabolism in RatsAspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency VirusThe gut microbiota: a major player in the toxicity of environmental pollutants?Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.Metabolic effects of non-nutritive sweetenersMonosodium L-glutamate and dietary fat exert opposite effects on the proximal and distal intestinal health in growing pigs.Non-caloric artificial sweeteners and the microbiome: findings and challenges.Consumption of caffeinated and artificially sweetened soft drinks is associated with risk of early menarche.Personalized microbiome-based approaches to metabolic syndrome management and prevention.Chronic Low-Calorie Sweetener Use and Risk of Abdominal Obesity among Older Adults: A Cohort StudyBehavioral Microbiomics: A Multi-Dimensional Approach to Microbial Influence on Behavior.Not-so-healthy sugar substitutes?Not so Sweet Revenge: Unanticipated Consequences of High-Intensity Sweeteners.Understanding the metabolic and health effects of low-calorie sweeteners: methodological considerations and implications for future research.Hormonal responses to non-nutritive sweeteners in water and diet soda.Roseburia spp.: a marker of health?Low-calorie sweetener use and energy balance: Results from experimental studies in animals, and large-scale prospective studies in humans.Artificial sweeteners and metabolic dysregulation: Lessons learned from agriculture and the laboratory.Biological fate of low-calorie sweeteners.Food additives, contaminants and other minor components: effects on human gut microbiota-a review.Aspartame intake is associated with greater glucose intolerance in individuals with obesity.Reply to RE Kleinman.Inhibition of the gut enzyme intestinal alkaline phosphatase may explain how aspartame promotes glucose intolerance and obesity in mice.Effects of Food Additives on Immune Cells As Contributors to Body Weight Gain and Immune-Mediated Metabolic Dysregulation.The Association Between Artificial Sweeteners and Obesity.Revisiting the safety of aspartame.The effect of moderate consumption of non-nutritive sweeteners on glucose tolerance and body composition in rats.Co-supplementation of isomalto-oligosaccharides potentiates metabolic health benefits of polyphenol-rich cranberry extract in high fat diet-fed mice via enhanced gut butyrate production.Endurance exercise training and high-fat diet differentially affect composition of diacylglycerol molecular species in rat skeletal muscle.Occurrence of artificial sweeteners in human liver and paired blood and urine samples from adults in Tianjin, China and their implications for human exposure.The Complex Interplay between Chronic Inflammation, the Microbiome, and Cancer: Understanding Disease Progression and What We Can Do to Prevent It.
P2860
Q26781277-DFAA64C7-3C22-4F94-9511-A2C96EB75BD4Q28081568-D0C9C7FF-F49B-4D00-9523-D3B70D779C44Q28088606-15D56763-E284-466E-B7AD-55516D6866B7Q28544662-526A8A3D-2C78-4096-A04B-8F26D19B2CDFQ29247903-E756C6A7-1E8B-4439-807B-9F1E9755871CQ30404383-8D29EE60-CC15-4F04-B552-540C1D4CFD30Q30410992-7C472A78-7975-4FB6-966F-AC9F56AF4BE3Q30410996-F40612C9-6C9C-4ED9-9082-265CD4A1C9B9Q30411186-322BADDF-12F0-48E9-AD8D-7369CA3458F3Q33749401-8B8EAD19-816C-464E-A2B1-B94DD8CF9066Q33878675-A2413DE8-8C5A-4AD6-A49F-362F4B7C6F39Q33914916-3839CB8D-2DBF-414C-86CA-C0914C2B5223Q34047368-C4606B2A-4411-4FDB-BF61-F49E2A490017Q34481610-F2F8B4F5-CB89-4903-A743-C01C9521EEE6Q35579440-BDC85A94-6ACF-40EC-A88B-2EEF626FDB0AQ35592115-1B8B0EE4-C787-4604-8E63-835CBEFAF840Q35992572-F6F6684B-BDC0-4385-875F-B5CA79CD4DD2Q36175953-0374DFAA-8E24-48CA-9B6D-7ABCF852454CQ36202623-8F74B6E6-E51F-45B8-A32C-C6FF5969A2DBQ36322977-779F32F1-EADA-4186-9443-DA159F15E5D9Q36839351-5FD4C604-A5C7-46C0-BDA1-C2136A877CBCQ36943520-B63D8C03-A8CE-4926-850E-2084A368A0A7Q37231000-2815AD1D-FE68-4CEB-A33A-D611C40B2C04Q37355803-CDB4EE02-E7C9-415A-880E-A5CC2CF24CE3Q38764022-C51E6919-B161-4B34-B986-FAFAAC40E539Q38821134-1F468BE4-7697-45A8-9FA6-96E575A8B171Q38888928-77FF3595-91D7-4F0B-91AF-FE13AB69569FQ38983827-45B46334-4A24-406D-B362-35AA89802523Q39294902-4911D09B-6910-4AE9-BF61-DD16DA0BB2EFQ40739878-63971EC9-069C-47B6-B1FE-0A25B54D6EE3Q43157293-E110C925-29A3-4D06-88F2-C11BC47F1710Q43433057-A7CA0D8D-A450-4C91-A5B6-1B1151BC5913Q46617053-5D428D0E-5F88-43E2-90F2-0190209F2C3CQ47437841-16F7FDC5-2A7B-419A-BD63-1C10F761A9EEQ47940291-EF8D4E88-A72C-4010-8D2B-9E6CEE644385Q47977540-23D097E7-C110-43DD-9E7D-930ECB3D1D96Q48321929-47FA51C3-D468-44D2-9F3E-504C32A2609AQ50004882-39F40DF9-B18A-48F0-A963-0C1B6E91F018Q51264165-85D8A870-0C11-4C79-AC45-75CD0088B7E3Q52349005-A4074976-20D0-431C-A842-5C5B24424C27
P2860
Low-dose aspartame consumption differentially affects gut microbiota-host metabolic interactions in the diet-induced obese rat.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@ast
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@en
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@nl
type
label
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@ast
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@en
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@nl
prefLabel
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@ast
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@en
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@nl
P2093
P2860
P1433
P1476
Low-dose aspartame consumption ...... in the diet-induced obese rat.
@en
P2093
Dustin S Hittel
Hans J Vogel
Jane Shearer
Marc R Bomhof
Marie S A Palmnäs
Raylene A Reimer
Theresa E Cowan
P2860
P304
P356
10.1371/JOURNAL.PONE.0109841
P407
P577
2014-10-14T00:00:00Z